Drug and Therapeutics Bulletin 1996;34:93-96; doi:10.1136/dtb.1996.341293
Copyright © 1996 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Long-acting progestogen-only contraception

Relevant BNF section: 7.3.2.2-3

The use of a long-acting progestogen preparation is one option for women who require contraception. Three formulations are licensed in the UK for long-term use. One (Depo-Provera - Pharmacia & Upjohn) is given as an intramuscular depot injection, a second ({blacktriangledown}Norplant - Hoechst Marion Roussel) as a sub-dermal implant and a third ({blacktriangledown}Mirena - Pharmacia-Leiras) releases progestogen from an intra-uterine system. In this article we review these preparations and consider how to choose between them.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1996 BMJ Publishing Group Ltd.